46 results on '"Amrutkar, Manoj"'
Search Results
2. HPTLC Estimation of Cefixime and Cloxacillin in Tablet Dosage Form
3. Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells
4. Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis
5. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice
6. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
7. Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells
8. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
9. Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma
10. Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle
11. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia
12. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
13. Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma.
14. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model
15. Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease
16. Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
17. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
18. Mo1138 COMPARATIVE PROTEOMICS REVEALS TRANSLATIONAL POTENTIAL OF TARGETS FOR PANCREATIC DUCTAL ADENOCARCINOMA
19. Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing
20. Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor
21. Additional file 3: of Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
22. Additional file 2: of Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
23. Additional file 8: of Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
24. Additional file 1: of Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
25. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
26. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans
27. Morphological heterogeneity in pancreatic ductal adenocarcinoma is associated with structural and functional divergence in the cancer cell population and stroma
28. In vitro characterization of different pancreatic stellate cell cultures commonly used for the study of human pancreatic cancer
29. Establishment and characterization of human PDAC-derived primary cancer cell lines
30. Comparative quantitative proteomic profiling of neoadjuvantly treated versus treatment-naive human pancreatic ductal adenocarcinoma
31. Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells
32. STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue
33. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic adenocarcinoma
34. In vitro characterization of different primary and immortalized pancreatic stellate cells
35. AB075. P047. Human pancreatic stellate cells secreted fibronectin promote chemoresistance to gemcitabine in PDAC
36. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice
37. Pancreatic Cancer Chemoresistance to Gemcitabine
38. Protein kinase STK25 is a regulator of hepatic lipid partitioning and whole body metabolism
39. Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle
40. STK25 is a critical determinant in nonalcoholic steatohepatitis
41. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
42. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
43. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH
44. Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained
45. Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes
46. Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high‐fat diet
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.